The covid-19 pandemic should be awakening us to valuable learning to be gained in many different areas and in particular for the issues and challenges of antimicrobial resistance (AMR).
We have seen the value of early research and scientific understanding. We have seen how, when necessary, regulatory processes can be speeded up (whilst not compromising on safety and quality).
There is so much to learn from different science and health aspects
(and also the economic impacts and politics, of course).
We need to be alert and prepared for the future as best we can.
Let’s make the most of what we have learnt!
by Dr Julie Charlesworth 29/3/21
This is a subject I have posted on several times before